PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.

Close

Today's Information

Provided by: PhytoHealth Corporation
SEQ_NO	2	Date of announcement	2022/04/08	Time of announcement	15:12:37
Subject	Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.
Date of events	2022/04/08	To which item it meets	paragraph 51
Statement	1.Date of occurrence of the event:2022/04/08 2.Company name:PhytoHealth Corporation 3.Relationship with the Company (please enter "the company itself" or "subsidiaries"):head office 4.Reciprocal shareholding percentage:NA 5.Name of the reporting media:NA 6.Content of the report:NA 7.Cause of occurrence: (1)As requested by Taiwan Stock Exchange Corporation's letter No.0970015839 issued on Jun.18,2008. (2)Committed items: When the company makes public disclosure of its financial statements in accordance with Securities and Exchange Act, it should also make public announcement of clinical development progress on anti-osteoporosis PH3 to help the investors understand the actual status of new drug R&D. At the same time, should be given indicating the pages of the company prospectus notewhere the workflow of different stages of new drug R&D. Progress:Full compliance.R&D progress of anti-osteoporosis PH3 was publicly announced;The product development has achieved phase 2a, and once we find an appropriate strategic partner, we will deal with them about licensing or expand clinical trial cooperation. 8.Countermeasures:NA 9.Any other matters that need to be specified:None